Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,241 to 2,260 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Histone modification aberrations in acute myeloid leukemia and the target therapy development in clinical settings]. | Zhonghua Xue Ye Xue Za Zhi | 2018 | 29562458 | PubTator, text mining | PubMed |
| [Efficacy analysis of unrelated cord blood transplantation in the treatment of refractory and relapsed adult acute leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2018 | 29562443 | PubTator, text mining | PubMed |
| PAN3-PSMA2 fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemia. | Exp Hematol Oncol | 2018 | 29560286 | PubTator, text mining | PubMed |
| [Role of autophagy in leukemia and research progress]. | Zhonghua Xue Ye Xue Za Zhi | 2018 | 29551045 | PubTator, text mining | PubMed |
| [Co-expression of PML-RARα and AML1-ETO rearrangements in a case with acute myeloid leukemia and literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2018 | 29551040 | PubTator, text mining | PubMed |
| [Secondary myelodysplastic syndrome in a patient with de novo t(8;21) acute myeloid leukemia: a case report and literatures review]. | Zhonghua Xue Ye Xue Za Zhi | 2018 | 29551034 | PubTator, text mining | PubMed |
| [Outcomes of adult patients with de novo acute myeloid leukemia received idarubicin plus cytarabine regimen as induction chemotherapy]. | Zhonghua Xue Ye Xue Za Zhi | 2018 | 29551027 | PubTator, text mining | PubMed |
| Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012. | Leukemia | 2018 | 29550834 | PubTator, text mining | PubMed |
| Dasatinib overrides the differentiation blockage in a patient with mutant-KIT D816V positive CBFβ-MYH11 leukemia. | Oncotarget | 2018 | 29545943 | PubTator, text mining | PubMed |
| Somatic mutations and increased lymphangiogenesis observed in a rare case of intramucosal gastric carcinoma with lymph node metastasis. | Oncotarget | 2018 | 29535844 | PubTator, text mining | PubMed |
| Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells. | J Cell Mol Med | 2018 | 29532991 | PubTator, text mining | PubMed |
| Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study. | Eur J Haematol | 2018 | 29532520 | PubTator, text mining | PubMed |
| Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms. | Blood Cancer J | 2018 | 29531217 | PubTator, text mining | PubMed |
| High-resolution detection of chromosomal rearrangements in leukemias through mate pair whole genome sequencing. | PLoS One | 2018 | 29529047 | PubTator, text mining | PubMed |
| Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia. | Front Oncol | 2018 | 29527516 | PubTator, text mining | PubMed |
| Dexamethasone in hyperleukocytic acute myeloid leukemia. | Haematologica | 2018 | 29519869 | PubTator, text mining | PubMed |
| ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation. | Leuk Res | 2018 | 29518627 | PubTator, text mining | PubMed |
| Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes. | Oncotarget | 2018 | 29507679 | PubTator, text mining | PubMed |
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology. | J Hematol Oncol | 2018 | 29495966 | PubTator, text mining | PubMed |
| MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death. | Ups J Med Sci | 2018 | 29493383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=113